These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 1338226)

  • 1. [Lymphoproliferative syndromes associated with Epstein-Barr virus in transplantation].
    Garnier JL; Touraine JL; Berger F; Magaud JP; Lefrançois N; Pouteil-Noble C; Betuel H; Martin X; Dubernard JM; Lenoir G
    Presse Med; 1992 Dec; 21(41):1994-6. PubMed ID: 1338226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epstein-Barr virus associated lymphoproliferative diseases (B cell lymphoma) after transplantation.
    Garnier JL; Berger F; Betuel H; Vuillaume M; Chapuis-Cellier C; Blanc N; Faure JL; Dubernard JM; Lenoir G; Touraine JL
    Nephrol Dial Transplant; 1989; 4(9):818-23. PubMed ID: 2560533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hodgkin's disease after transplantation.
    Garnier JL; Lebranchu Y; Dantal J; Bedrossian J; Cahen R; Assouline D; Jaccard A; Fetissoff F; Moreau A; Martin X; Delsol G; Berger F; Touraine JL
    Transplantation; 1996 Jan; 61(1):71-6. PubMed ID: 8560577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Lymphoma with bladder involvement and renal transplantation].
    Chebil M; Martin X; Friaa S; Ezzeddine W; Garnier JL; Desmettre O; Maréchal JM; Gelet A; Dubernard JM
    Prog Urol; 1995 Feb; 5(1):102-5. PubMed ID: 7719353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Humanized anti-CD20 monoclonal antibody (Rituximab) in post transplant B-lymphoproliferative disorder: a retrospective analysis on 32 patients.
    Milpied N; Vasseur B; Parquet N; Garnier JL; Antoine C; Quartier P; Carret AS; Bouscary D; Faye A; Bourbigot B; Reguerre Y; Stoppa AM; Bourquard P; Hurault de Ligny B; Dubief F; Mathieu-Boue A; Leblond V
    Ann Oncol; 2000; 11 Suppl 1():113-6. PubMed ID: 10707791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-Barr virus lymphoproliferative disease associated with acquired immunodeficiency.
    Cohen JI
    Medicine (Baltimore); 1991 Mar; 70(2):137-60. PubMed ID: 1848644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Posttransplantation lymphoproliferative disorder in liver recipients: characteristics, management, and outcome.
    Ben-Ari Z; Amlot P; Lachmanan SR; Tur-Kaspa R; Rolles K; Burroughs AK
    Liver Transpl Surg; 1999 May; 5(3):184-91. PubMed ID: 10226108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-B cell antibodies for the treatment of monoclonal Epstein-Barr virus-induced lymphoproliferative syndrome after multivisceral transplantation.
    Lazarovits AI; Tibbles LA; Grant DR; Ghent CN; Wall WJ; White MJ; Joncas JH
    Clin Invest Med; 1994 Dec; 17(6):621-5. PubMed ID: 7895425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Posttransplant lymphoproliferative disorder in a kidney-pancreas transplanted recipient: simultaneous development of clonal lymphoid B-cell proliferation of host and donor origin.
    Heyny-von Haussen R; Klingel K; Riegel W; Kandolf R; Mall G
    Am J Surg Pathol; 2006 Jul; 30(7):900-5. PubMed ID: 16819335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-B-cell monoclonal antibodies in the treatment of severe B-cell lymphoproliferative syndrome following bone marrow and organ transplantation.
    Fischer A; Blanche S; Le Bidois J; Bordigoni P; Garnier JL; Niaudet P; Morinet F; Le Deist F; Fischer AM; Griscelli C
    N Engl J Med; 1991 May; 324(21):1451-6. PubMed ID: 2023604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical spectrum of lymphoproliferative disorders in renal transplant recipients and evidence for the role of Epstein-Barr virus.
    Hanto DW; Frizzera G; Purtilo DT; Sakamoto K; Sullivan JL; Saemundsen AK; Klein G; Simmons RL; Najarian JS
    Cancer Res; 1981 Nov; 41(11 Pt 1):4253-61. PubMed ID: 6272971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sustained remission of an extensive monoclonal, Epstein-Barr virus-associated diffuse large B cell lymphoma in a kidney-pancreas transplant recipient.
    Manz MG; Berger C; Horny HP; Beck R; Brugger W; Viebahn R; Kanz L; Knecht H
    Transplantation; 2002 Mar; 73(6):995-7. PubMed ID: 11923707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diffuse large B-cell lymphoma arising from donor lymphoid cells after renal and pancreatic transplantation.
    Cibeira MT; Lopez-Guillermo A; Colomer D; Ricart MJ; Alcaraz A; Martinez A; Campo E; Montserrat E
    Ann Hematol; 2003 Feb; 82(2):131-135. PubMed ID: 12601496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management and outcome of liver recipients with post-transplant lymphoproliferative disease.
    Glez-Chamorro A; Jimenez C; Moreno-Glez E; Glez-Pinto I; Loinaz C; Gomez R; Garcia I; Alonso O; Palma F; Grande C
    Hepatogastroenterology; 2000; 47(31):211-9. PubMed ID: 10690611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EBV-positive extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue in the posttransplant setting: a distinct type of posttransplant lymphoproliferative disorder?
    Gibson SE; Swerdlow SH; Craig FE; Surti U; Cook JR; Nalesnik MA; Lowe C; Wood KM; Bacon CM
    Am J Surg Pathol; 2011 Jun; 35(6):807-15. PubMed ID: 21552113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiviral prophylaxis and the Epstein Barr virus-related post-transplant lymphoproliferative disorder.
    Davis CL; Harrison KL; McVicar JP; Forg PJ; Bronner MP; Marsh CL
    Clin Transplant; 1995 Feb; 9(1):53-9. PubMed ID: 7742583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pretransplantation seronegative Epstein-Barr virus status is the primary risk factor for posttransplantation lymphoproliferative disorder in adult heart, lung, and other solid organ transplantations.
    Walker RC; Paya CV; Marshall WF; Strickler JG; Wiesner RH; Velosa JA; Habermann TM; Daly RC; McGregor CG
    J Heart Lung Transplant; 1995; 14(2):214-21. PubMed ID: 7779838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epstein-Barr virus-negative high grade B cell lymphoma of donor origin developing 19 months after unrelated allogeneic bone marrow transplantation.
    Gomyo H; Murayama T; Kizaki T; Mizuno I; Kitaori K; Sao H; Tobinai K; Koizumi K; Imoto S
    Bone Marrow Transplant; 2000 Sep; 26(5):577-9. PubMed ID: 11019851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunoblastic lymphoma after bone marrow graft. Apropos of a case treated by OKT3 monoclonal antibodies for an acute graft versus host reaction].
    Faure P; d'Agay MF; Tricot G; Gluckman E; Brocheriou C
    Ann Pathol; 1986; 6(2):137-43. PubMed ID: 3015160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thoracic presentations of posttransplant lymphoproliferative disorders.
    Halkos ME; Miller JI; Mann KP; Miller DL; Gal AA
    Chest; 2004 Dec; 126(6):2013-20. PubMed ID: 15596707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.